Financials
- Market Capitalization 8.75 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-3 449
売上高対価格比率
5.56
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 959 | AXSM Axsome Therapeutics, Inc. - Common Stock | 169.03 USD | +0.40% | -4.67% | -23.84% | +29.82% | 8.85 B USD | ||
| 965 | CYTK Cytokinetics, Incorporated - Common Stock | 62.93 USD | +0.03% | -2.04% | -14.39% | +8.31% | 8.75 B USD | ||
| 982 | TGTX TG Therapeutics, Inc. - Common Stock | 55.75 USD | +0.69% | +2.46% | +3.30% | +65.58% | 8.53 B USD | ||
| 1044 | SYRE Spyre Therapeutics, Inc. - Common Stock | 85.16 USD | -0.62% | -7.98% | -6.00% | +256.17% | 7.51 B USD |